80 related articles for article (PubMed ID: 8519036)
1. Treatment of post-transplant diabetic patients.
White JR; Campbell RK
Clin Ther; 1993; 15(2):261-71; discussion 215. PubMed ID: 8519036
[TBL] [Abstract][Full Text] [Related]
2. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
[TBL] [Abstract][Full Text] [Related]
3. Post transplant diabetes mellitus in live related renal allograft recipients: a single centre experience.
Saxena S; Dash SC; Guleria S; Mittal R; Agarwal SK; Tiwari SC; Mehta SN
J Assoc Physicians India; 1996 Jul; 44(7):472, 477-9. PubMed ID: 9282609
[TBL] [Abstract][Full Text] [Related]
4. Natural history, prognosis, and management of transplantation-induced diabetes mellitus.
Benhamou PY; Penfornis A
Diabetes Metab; 2002 Jun; 28(3):166-75. PubMed ID: 12149596
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant diabetes mellitus.
Salvadori M; Bertoni E; Rosati A; Zanazzi M
J Nephrol; 2003; 16(5):626-34. PubMed ID: 14733407
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and nutritional complications of renal transplantation.
Dumler F; Kilates C
J Ren Nutr; 2007 Jan; 17(1):97-102. PubMed ID: 17198943
[TBL] [Abstract][Full Text] [Related]
8. Pancreas-kidney transplantation in Japan: impact of cyclosporine on the development of immunosuppressive therapy.
Sugitani A; Ishibashi M; Ito T; Nakajima K; Matsuno N; Kanazawa Y; Motoyama K; Yamamoto H; Inoue S; Ota M; Yoshida JI; Tanaka M
Transplant Proc; 2004 Mar; 36(2 Suppl):356S-361S. PubMed ID: 15041368
[TBL] [Abstract][Full Text] [Related]
9. OKT3 therapy increases cyclosporine blood levels.
Vasquez EM; Pollak R
Clin Transplant; 1997 Feb; 11(1):38-41. PubMed ID: 9067693
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
11. Renal transplantation in diabetic patients.
Bittar J; Cepeda P; de la Fuente J; Douthat W; de Arteaga J; Massari PU
Transplant Proc; 2006 Apr; 38(3):895-8. PubMed ID: 16647502
[TBL] [Abstract][Full Text] [Related]
12. [Hypertension after kidney transplantation].
Racki S
Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
[TBL] [Abstract][Full Text] [Related]
13. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
Hoitsma AJ; Hilbrands LB
Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
[TBL] [Abstract][Full Text] [Related]
14. [Long-term results in pancreas transplantation in diabetes in the pre-cyclosporin era].
Largiadèr F
Schweiz Med Wochenschr; 1996 Aug; 126(34):1433-6. PubMed ID: 8848705
[TBL] [Abstract][Full Text] [Related]
15. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.
Launay-Vacher V; Izzedine H; Deray G
Int J Cardiol; 2005 May; 101(1):9-17. PubMed ID: 15860377
[TBL] [Abstract][Full Text] [Related]
16. Ten-year experience with human pancreatic transplantation.
Tellis VA; Veith FJ; Gliedman ML
Transplant Proc; 1980 Dec; 12(4 Suppl 2):78-80. PubMed ID: 7013210
[No Abstract] [Full Text] [Related]
17. Liver transplantation eliminates insulin needs of a diabetic patient.
Vlaeminck-Guillem V; Guillem P; Dequiedt P; Pruvot FR; Fontaine P
Diabetes Metab; 2000 Dec; 26(6):493-6. PubMed ID: 11173721
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
Cantarovich D
J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
Pietruck F; Budde K; Salvadori M; Sollinger H; Bourbigot B; Gentil MA; Oppenheimer F
Clin Transplant; 2007; 21(1):117-25. PubMed ID: 17302600
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
